UPDATE: Cantor Fitzgerald Downgrades Eagle Pharmaceuticals (EGRX) to Neutral
Tweet Send to a Friend
(Updated - November 1, 2018 12:57 PM EDT)
Cantor Fitzgerald analyst Brandon Folkes downgraded Eagle Pharmaceuticals (NASDAQ: EGRX) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Cantor Fitzgerald analyst Brandon Folkes downgraded Eagle Pharmaceuticals (NASDAQ: EGRX) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
